Mark S. Schroeder - 30 Mar 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
30 Mar 2023
Net transactions value
-$1,523,972
Form type
4
Filing time
03 Apr 2023, 10:05:26 UTC
Previous filing
16 Feb 2023
Next filing
09 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Award $0 +6,763 +101% $0.000000 13,450 30 Mar 2023 Direct F1
transaction LH Common Stock Tax liability $643,990 -2,866 -21% $224.70 10,584 30 Mar 2023 Direct F2
transaction LH Common Stock Sale $879,982 -3,897 -37% $225.81 6,687 31 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares acquired on March 30, 2023, pursuant to a performance award granted on February 4, 2020, relating to performance during the three-year period ended December 31, 2022.
F2 Stock withholding to satisfy tax withholding obligations.
F3 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.